Additional information
| Strength | 10mg |
|---|
CJC-1295 (No DAC) + Ipamorelin
$70.00
Product Classification
Classified as a combined GHRH + GHRP research regimen
Description
The combination of CJC-1295 without DAC and Ipamorelin is explored for synergistic modulation of GH signaling, leveraging GHRH and GHRP pathways to enhance pulsatile GH release in preclinical models.
Specifications
- Molecular Typ: Peptide combination
- Mechanism: Dual-path GH axis activation
Research Notes
- Synergy: combined action yields greater GH pulse amplitude than monotherapy in research models.
- Pulsatility: no DAC variant supports physiologic pulse patterns.
- IGF-1: increases observed in metabolic and body composition frameworks.
- Research Interest: widely used in endocrine and performance-related studies.
Regulatory Statement
For research use only. Not for human or animal consumption.
Not evaluated by FDA. Not intended to diagnose, treat, cure, or prevent disease
Related products
-
B7-33 (Modified Relaxin-2 Analog)
Price range: $58.00 through $200.00 Select options This product has multiple variants. The options may be chosen on the product page -
BPC-157
Price range: $30.00 through $65.00 Select options This product has multiple variants. The options may be chosen on the product page -
– ACE-031 (Soluble Activin Receptor Type IIB-Fc Fusion Protein)
$40.00 Select options This product has multiple variants. The options may be chosen on the product page -
Cagrilintide (Amylin Analogue)
Price range: $110.00 through $160.00 Select options This product has multiple variants. The options may be chosen on the product page
Reviews
There are no reviews yet.